Clonality and antigen-specific responses shape the prognostic effects of tumor-infiltrating T cells in ovarian cancer

Oncotarget
Takemasa TsujiKunle Odunsi

Abstract

CD8+ tumor-infiltrating lymphocytes (TILs) are not all specific for tumor antigens, but can include bystander TILs that are specific for cancer-irrelevant epitopes, and it is unknown whether the T-cell repertoire affects prognosis. To delineate the complexity of anti-tumor T-cell responses, we utilized a computational method for de novo assembly of sequences from CDR3 regions of 369 high-grade serous ovarian cancers from TCGA, and then applied deep TCR-sequencing for analyses of paired tumor and peripheral blood specimens from an independent cohort of 99 ovarian cancer patients. Strongly monoclonal T-cell repertoires were associated with favorable prognosis (PFS, HR = 0.65, 0.50-0.84, p = 0.003; OS, HR = 0.61, 0.44-0.83, p = 0.006) in TCGA cohort. In the validation cohort, we discovered that patients with low T-cell infiltration but low diversity or focused repertoires had clinical outcomes almost indistinguishable from highly-infiltrated tumors (median 21.0 months versus 15.9 months, log-rank p = 0.945). We also found that the degree of divergence of the peripheral repertoire from the TIL repertoire, and the presence of detectable spontaneous anti-tumor immune responses are important determinants of clinical outcome. We conclu...Continue Reading

References

Apr 26, 2000·Proceedings of the National Academy of Sciences of the United States of America·E JägerA Knuth
Sep 27, 2000·Proceedings of the National Academy of Sciences of the United States of America·S GnjaticL J Old
Jan 17, 2003·The New England Journal of Medicine·Lin ZhangGeorge Coukos
Jul 11, 2003·Proceedings of the National Academy of Sciences of the United States of America·Sacha GnjaticLloyd J Old
Dec 14, 2005·Proceedings of the National Academy of Sciences of the United States of America·Eiichi SatoKunle Odunsi
Jul 20, 2007·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Timothy J DuncanLindy G Durrant
Jul 27, 2007·Proceedings of the National Academy of Sciences of the United States of America·Kunle OdunsiSacha Gnjatic
Apr 22, 2009·Methods in Molecular Biology·Sacha GnjaticYao-Tseng Chen
Apr 14, 2010·Proceedings of the National Academy of Sciences of the United States of America·Junko MatsuzakiKunle Odunsi
May 25, 2010·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Xingxing ZangJames P Allison
Feb 2, 2011·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Paul F RobbinsSteven A Rosenberg
Jul 2, 2011·Nature·UNKNOWN Cancer Genome Atlas Research Network
Nov 2, 2011·Gynecologic Oncology·Wei-Ting HwangGeorge Coukos
Mar 29, 2012·Proceedings of the National Academy of Sciences of the United States of America·Kunle OdunsiElke Jäger
Oct 4, 2012·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Paul SabbatiniSacha Gnjatic
Apr 13, 2013·Current Opinion in Immunology·Helen Angell, Jérôme Galon
Sep 21, 2013·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Qunrui YeDaniel J Powell
Oct 26, 2013·Nature Communications·Christopher S CarlsonHarlan Robins
Nov 28, 2013·Proceedings of the National Academy of Sciences of the United States of America·Joanne L JonesAlasdair J Coles
Feb 19, 2014·Cancer Immunology Research·Kunle OdunsiAdam R Karpf
Mar 4, 2014·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Lidia RobertAntoni Ribas
Mar 29, 2014·The Journal of Clinical Investigation·Alena GrosSteven A Rosenberg
May 20, 2014·International Journal of Cancer. Journal International Du Cancer·Inka ZörnigDirk Jäger
May 30, 2014·Science Translational Medicine·Edward ChaLawrence Fong
Nov 20, 2014·The New England Journal of Medicine·Alexandra SnyderTimothy A Chan
Dec 30, 2014·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Paul F RobbinsSteven A Rosenberg
Jan 18, 2015·Clinical Immunology : the Official Journal of the Clinical Immunology Society·Manish RameshCharlotte Cunningham-Rundles
Mar 1, 2015·The Journal of Immunology : Official Journal of the American Association of Immunologists·Fayçal DjenidiFathia Mami-Chouaib
May 1, 2015·Science Translational Medicine·Patrick J HanleyCatherine M Bollard
Sep 19, 2015·Gynecologic Oncology·Kevin H EngJ Brian Szender
Nov 27, 2015·Science Translational Medicine·Jeffrey A BluestoneQizhi Tang
Feb 26, 2016·Science Translational Medicine·Bernhard MlecnikJérôme Galon
May 31, 2016·Nature Genetics·Bo LiX Shirley Liu
Apr 11, 2017·Gynecologic Oncology·J Brian SzenderKunle Odunsi
Oct 20, 2017·JAMA Oncology·UNKNOWN Ovarian Tumor Tissue Analysis (OTTA) ConsortiumSusan J Ramus

❮ Previous
Next ❯

Methods Mentioned

BETA
RNA-seq
ELISA
PCR

Software Mentioned

TRUST
TRUST ( Tcr Receptor Utilities for Solid Tissue )
R

Related Concepts

Related Feeds

Antibody Repertoire Diversity

Antibody repertoire diversity and its role during natural infection is a prerequisite for molecular and structural elucidation of functionally protective immunity. Discover the latest insights into antibody diversity here.